Foundation stone for “Hidayah Share and Care Colony” laid at Kavalakatte

Bengaluru, Feb 21: A young woman in Bengaluru was detained today for holding a placard saying ''Free Kashmir'' at a demonstration in the city to protest against the arrest of college student Amulya Leona who had raised pro-Pakistan slogans at an anti-CAA rally a day ago.

The arrested has been identified as Ardra Narayan, a 20-year-old student of an engineering college at Malleshwaram in the city's western suburb.

"Ardra Narayan is being questioned at the Silver Jubilee Park police station after she was whisked away from the spot and detained for holding the placard with ''Free Kashmir'' written on it," Bengaluru Police Commissioner Bhaskar Rao said.

On a complaint by Sri Ram Sena activists, who were protesting against Amulya at the venue, the police booked a suo moto case against Ardra under sections 153A and 153B of the IPC (Indian Penal Code) for disturbing peace and harmony.

The placard also displayed ''Give Us Liberation'' and ''Freedom from India'', a Sri Ram Sena activist alleged.

The development comes a day after Amulya, 19, was arrested under section 124A of the IPC for sedition and jailed for 14 days for allegedly shouting "Pakistan Zindabad" at the anti-Citizenship Amendment Act (CAA) rally at Freedom Park in the city centre on Thursday.

"We are trying to ascertain if there is any connection between Amuly and Ardra though she was alone at the spot holding the placard," Assistant Commissioner of Police (ACP) R. Chandrashekar told news agency.

Bengaluru, Mar 7: Karnataka Chief Minister BS Yediyurappa on Friday said that the Upper Krishna Project (UKP) will be completed within the next three years.

Speaking in the Assembly, the Chief Minister said: "After discussing with the officials of the finance department, we have decided to allocate Rs 10,000 crore funds for the third phase of UKP. This project will be completed within a span of three years."

Yediyurappa also said that the government will hold talks for additional funds from the Central government.

The leader of Opposition, Siddaramaiah, interrupted and said that the CM has announced this just to gain the confidence of MLAs from north Karnataka.

"The government could have announced it in the budget itself or else the Chief Minister could have announced it at the time of discussion on the budget. Where are the funds with the government to complete the project? CM has announced this just to gain the confidence of MLAs who hail from north Karnataka," said Siddaramaiah.

Deputy Chief Minister Govinda Karajol while speaking to the media welcomed the Chief Minister's statement and said that the earlier government didn't allocate a single penny in the last seven years he added.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.